Updated immunisation reference page: Older population’s immunisation recommendations
MVEC has recently updated its older population’s immunisation recommendations reference page to reflect the 1 July 2026 changes to the adult phế cầu khuẩn vaccination schedule.
All adults are recommended and funded to receive one dose of Capvaxive from 65 years of age.
MVEC: Older population’s immunisation recommendations
Updated immunisation reference page: Asplenia and hyposplenia
MVEC has recently updated its asplenia and hyposplenia immunisation reference page to reflect the 1 July 2026 changes to the adult phế cầu khuẩn vaccination schedule.
All adults living without a functioning spleen are recommended to receive one dose of Capvaxive as soon as possible, and at least 12 months following their last dose of any pneumococcal vaccine.
Updated immunisation reference page: Aboriginal and Torres Strait Islander peoples’ immunisation recommendations
MVEC has recently updated its Aboriginal and Torres Strait Islander peoples’ immunisation recommendations reference page to reflect the 1 July 2026 changes to the adult phế cầu khuẩn vaccination schedule.
First Nations Australians are recommended and funded to receive one dose of Capvaxive from 25 years of age.
The page includes an updated summary table of the vaccines prioritised for Aboriginal and Torres Strait Islander individuals under the National Immunisation Program and jurisdictional programs. The summary table has been simplified and is now ordered by age, then jurisdiction.
MVEC: Aboriginal and Torres Strait Islander peoples’ immunisation recommendations
Updated immunisation reference page: Pneumococcal
MVEC recently updated in pneumococcal reference page to reflect upcoming changes to the National Immunisation Program. From 1 July 2026, the vaccine Capvaxive will replace Prevenar 13 and Pneumovax 23 for adults.
The newly updated page includes information on Capvaxive administration and groups eligible to be vaccinated under the NIP.
New immunisation reference page: Inborn errors of immunity
MVEC recently published a new immunisation reference page on inborn errors of immunity (IEI, previously referred to as primary immunodeficiencies). IEIs comprise a broad group of inherited disorders affecting one or more components of the immune system.
The new reference page outlines immunisation recommendations, contraindications and responses to commonly asked questions.
MVEC: Inborn errors of immunity
New immunisation reference page: Discoloured leg syndrome
MVEC has published a new immunisation reference page on the rare phenomenon of discoloured leg syndrome (DLS). DLS is a transient condition that can occur after an individual receives an injected vaccine.
The new reference page includes information on DLS diagnosis, association and incidence, treatment, and implications for future vaccine doses.
MVEC: Discoloured leg syndrome
Updated immunisation reference page: Respiratory syncytial virus (RSV)
MVEC has recently updated its RSV immunisation reference page to reflect the upcoming addition of RSV vaccination for older adults to the National Immunisation Program (NIP).
The updated page includes details on RSV vaccines (for adults only, there are no vaccines registered for infants/children) and monoclonal antibodies, as well as information on disease transmission and epidemiology.
MVEC: Virus hợp bào hô hấp (RSV)
Updated immunisation reference page: Older population's immunisation recommendations
MVEC has updated its older population's immunisation recommendations reference page to reflect the addition of respiratory syncytial virus (RSV) vaccination to the National Immunisation Program (NIP) for older adults.
The page provides background information on the immunisation needs of older adults, and outlines vaccine recommendations for older adults (both funded and un-funded vaccines).
Visit the newly updated page at MVEC: Older population's immunisation recommendations.
Updated immunisation reference page: Translated 2026 influenza page
Translated version of MVEC’s recently updated 2026 influenza reference page are now available. This reference is available to read in Vietnamese, Hindi and Simplified Chinese.
MVEC’s influenza reference page details recommendations for flu vaccination in 2026, including:
- influenza strains included in this year’s vaccines
- brands available by age and funding
- commonly asked questions.
Switch between languages using the dropdown box at the beginning of the page.
MVEC: Cúm
New immunisation reference page: Dengue
Dengue, or dengue fever, is a viral illness caused by infection with the dengue virus (DENV). Primarily transmitted via mosquitos, dengue is endemic in more than 100 countries across tropical and sub-tropical areas in the Pacific, Asia, Africa and the America.
MVEC has recently published a new immunisation reference page on dengue, which includes information on symptoms and transmission, epidemiology, and prevention.